Xiang‐Yang Ye

4 ta ish

Hangzhou Normal University

1. Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective

   Yuan Gao, Hang Zhang, Frédéric Lirussi +3

   Sharh maqolaOAOchiq kirish20202 iqtibos

   ABIABI:AkademIndex/2026.other.047779

2. Small molecule DNA-PK inhibitors as potential cancer therapy: a patent review (2010–present)

   Suwen Hu, Zi Hui, Frédéric Lirussi +3

   Sharh maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.047783

3. Races of small molecule clinical trials for the treatment of COVID‐19: An up‐to‐date comprehensive review

   Suwen Hu, Songwei Jiang, Qi Xiang +3

   Sharh maqolaOAOchiq kirish20212 iqtibos

   ABIABI:AkademIndex/2026.other.243864

4. Design, Synthesis, and Structure–Activity Relationship of Novel Pyridazinone-Based PARP7/HDACs Dual Inhibitors for Elucidating the Relationship between Antitumor Immunity and HDACs Inhibition

   Ji‐Long Duan, Chenchen Wang, Yinghui Yuan +10

   Maqola20242 iqtibos

   ABIABI:AkademIndex/2026.other.422034